Catalyst Wire Dossier Catalyst Wire Dossier

Tri-betahydroxybutyrin

· NeuroEnergy Ventures, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tri-betahydroxybutyrin, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Human Pharmacokinetics of a Medical Food Containing Tri-betahydroxybutyrin [NA]

See pricing